FULLER & THALER ASSET MANAGEMENT, INC. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
FULLER & THALER ASSET MANAGEMENT, INC. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$3,558,000
+3.1%
1,129,470
-4.8%
0.04%0.0%
Q2 2020$3,452,000
+0.6%
1,186,100
-2.5%
0.04%
-22.4%
Q1 2020$3,431,000
-4.7%
1,216,690
+9.7%
0.06%
+45.0%
Q4 2019$3,599,000
+50.6%
1,109,145
+0.3%
0.04%
+42.9%
Q3 2019$2,389,000
-38.8%
1,105,970
-11.0%
0.03%
-37.8%
Q2 2019$3,903,000
-16.1%
1,243,125
-0.6%
0.04%
-23.7%
Q1 2019$4,650,000
+30.2%
1,250,040
+1.5%
0.06%
+15.7%
Q4 2018$3,572,000
+12.2%
1,231,730
+1.7%
0.05%
+54.5%
Q3 2018$3,185,000
+12.4%
1,211,1500.0%0.03%
+6.5%
Q2 2018$2,834,000
-20.4%
1,211,150
-0.0%
0.03%
-26.2%
Q1 2018$3,561,000
+0.2%
1,211,300
-6.6%
0.04%
-2.3%
Q4 2017$3,555,000
-38.4%
1,297,300
-23.8%
0.04%
-39.4%
Q3 2017$5,768,000
+36.6%
1,701,500
-0.5%
0.07%
+29.1%
Q2 2017$4,222,000
+163.9%
1,709,500
+142.6%
0.06%
+150.0%
Q1 2017$1,600,000704,8000.02%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders